- Filed
- May 4, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 127.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 154.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 107.2M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $32K |
| Capex | Q1 2026 · Mar 31, 2025 | $264K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$29.71M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$56.33M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $4.64M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $3M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $231.01M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $261.34M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$216.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$185.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$238.22M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$202.64M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $67.63M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $70.16M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $507.87M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $508.98M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $276.77M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $306.34M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $291.5M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $323.15M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.21 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.36 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.36 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.9M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $9.96M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $19.88M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $28.93M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$32.97M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$38.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$25.25M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$28.46M |
| Revenue | Q1 2026 · Mar 31, 2026 | $20.03M |
| Revenue | Q1 2026 · Mar 31, 2025 | $17.4M |